Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.5bn2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥9.3bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥2.2bn2022-01-01 → 2022-03-31Cons.Net sales
Operating income¥715m2023-01-01 → 2023-03-31Cons.Operating income
Operating income¥838m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income¥716m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥2.9bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥839m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥716m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥839m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥458m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥558m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥464m2023-01-01 → 2023-03-31Cons.Profit loss
Net income¥564m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥12.4bnat 2023-03-31Cons.Assets
Total assets¥13.1bnat 2022-12-31Cons.Assets
Total assets¥10.1bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.2bnat 2023-03-31Cons.Liabilities
Total liabilities¥3.1bnat 2022-12-31Cons.Liabilities
Net assets / equity¥10.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥8.4bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥7.8bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥7.8bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥10.272023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.72022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.612022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥336m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥985m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥66m
—segment totalrevenue2023-01-01 → 2023-03-31¥2.5bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥2.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥308m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥2.0bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥2.0bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥1.1bn
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥207m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥207m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥88m
—segment totalrevenue2022-01-01 → 2022-03-31¥2.2bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥2.2bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 327
ItemContextValueUnit
Foreign exchange gains noiCurrentYTDDuration194000JPY
Miscellaneous income noiPrior1YTDDuration740000JPY
Miscellaneous income noiCurrentYTDDuration1202000JPY
Non operating incomePrior1YTDDuration6468000JPY
Non operating incomeCurrentYTDDuration1984000JPY
Interest expenses noePrior1YTDDuration294000JPY
Interest expenses noeCurrentYTDDuration261000JPY
Stock issuance cost noePrior1YTDDuration2845000JPY
Stock issuance cost noeCurrentYTDDuration0JPY
Loss on investments in partnership noePrior1YTDDuration2296000JPY
Loss on investments in partnership noeCurrentYTDDuration95000JPY
Miscellaneous loss noePrior1YTDDuration-JPY
Miscellaneous loss noeCurrentYTDDuration994000JPY
Non operating expensesPrior1YTDDuration5436000JPY
Non operating expensesCurrentYTDDuration1352000JPY
Ordinary incomePrior1YTDDuration839065000JPY
Ordinary incomeCurrentYTDDuration715693000JPY
Income before income taxesPrior1YTDDuration839065000JPY
Income before income taxesCurrentYTDDuration715693000JPY
Income taxes currentPrior1YTDDuration220441000JPY
Income taxes currentCurrentYTDDuration221113000JPY
Income taxes deferredPrior1YTDDuration54448000JPY
Income taxes deferredCurrentYTDDuration30497000JPY
Income taxesPrior1YTDDuration274890000JPY
Income taxesCurrentYTDDuration251610000JPY
Profit lossPrior1YTDDuration564175000JPY
Profit lossCurrentYTDDuration464082000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration5965000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration6389000JPY
Profit loss attributable to owners of parentPrior1YTDDuration558209000JPY
Profit loss attributable to owners of parentCurrentYTDDuration457693000JPY
Profit lossPrior1YTDDuration564175000JPY
Profit lossCurrentYTDDuration464082000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-141866000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-11188000JPY
Other comprehensive incomePrior1YTDDuration-141866000JPY
Other comprehensive incomeCurrentYTDDuration-11188000JPY
Comprehensive incomePrior1YTDDuration422308000JPY
Comprehensive incomeCurrentYTDDuration452894000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration416342000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration446504000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration5965000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration6389000JPY
Finished goodsPrior1YearInstant6974000JPY
Finished goodsCurrentQuarterInstant6963000JPY
Work in processPrior1YearInstant17650000JPY
Work in processCurrentQuarterInstant25796000JPY
SuppliesPrior1YearInstant2429000JPY
SuppliesCurrentQuarterInstant1897000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember2016017000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass